Form 8-K - Current report:
SEC Accession No. 0001683168-24-007100
Filing Date
2024-10-11
Accepted
2024-10-11 16:20:32
Documents
14
Period of Report
2024-10-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k.htm   iXBRL 8-K 35785
  Complete submission text file 0001683168-24-007100.txt   262155

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE acon-20241008.xsd EX-101.SCH 3788
3 XBRL DEFINITION FILE acon-20241008_def.xml EX-101.DEF 30055
4 XBRL LABEL FILE acon-20241008_lab.xml EX-101.LAB 36765
5 XBRL PRESENTATION FILE acon-20241008_pre.xml EX-101.PRE 27078
16 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 241367787
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)